Physician profile
Rahul M Varman
NPI 1023539426
$12,854.16
in general payments reported to CMS, 2019-2025
23 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $1,436 · 2021: $74.67 · 2022: $3,465 · 2023: $278 · 2024: $5,655 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,420 · Food and Beverage: $2,165 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,419.88 |
| Food and Beverage | $2,165.36 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,808.07 | 2020-2024 | Na, Smartlock, Colorado |
| Aerin Medical INC. | $1,525.99 | 2025 | |
| Medtronic, INC. | $1,224.59 | 2022-2025 | Nim Vital |
| Axogen | $1,217.40 | 2019-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Integra Lifesciences Corporation | $367.67 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Intersect Ent, INC. | $123.35 | 2020 | |
| Acclarent, INC | $89.42 | 2019 | |
| Bausch & Lomb Americas INC. | $88.87 | 2024 | Vyzulta |
| Abbvie INC. | $85.46 | 2023-2024 | |
| Polynovo North America LLC | $44.94 | 2025 | Novosorb Btm |
| Kls-Martin L.P. | $36.48 | 2020 | |
| Janssen Biotech, INC. | $35.63 | 2024 | Tremfya |
| Optinose US, INC. | $28.28 | 2023 | |
| Smith+Nephew, INC. | $27.85 | 2024 | Ent Sinus, Rf20000 |
| Amgen INC. | $25.01 | 2025 | Tezspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $24.02 | 2025 | Inspire |
| Depuy Synthes Sales INC. | $19.08 | 2023 | Trumatch |
| Astrazeneca Pharmaceuticals Lp | $15.96 | 2025 | |
| Galderma Laboratories, L.P. | $15.52 | 2023 | |
| Tactile Systems Technology INC | $14.79 | 2021 | |
| Advanced Bionics, LLC | $13.68 | 2019 | |
| Cardinal Health 414 LLC | $11.18 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Varman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.